Article
Association between Retinoic acid receptor-β hypermethylation and NSCLC risk: a meta-analysis and literature review.
Oncotarget - 24 Jan 2017
Li Yan, Lu De-Guo, Ma Ying-Mei, Liu Hongxiang
Abstract excerpt
Emerging evidence indicates that Retinoic acid receptor-β (RARβ) is a tumor suppressor in many types of tumor. However, whether or not RARβ is a risk factor and is correlated to clinicopathological characteristics of non-small cell lung cancer (NSCLC) remains unclear. In this report, we performed a meta-analysis to determine the effects of RARβ hypermethylation on the incidence of NSCLC and clinicopathological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
